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Abstract
A 1-year-old Australian Shepherd (AS) was presented for a routine hereditary eye examination. During the
examination multiple raised, brown to orange lesions were noted in the fundus, which could not be
attributed to a known retinal disease in this breed. As they clinically most closely resembled canine
multifocal retinopathy (cmr) and no indication of an acquired condition was found, genetic tests for
BEST1 gene mutations were performed. These showed the dog to be homozygous for the cmr1 (C73T/
R25X) gene defect. Furthermore, ultrasound (US), electroretinography (ERG), and optical coherence
tomography were performed, confirming changes typical for cmr. Subsequently, the AS pedigree
members were genetically and clinically tested, demonstrating autosomal recessive inheritance with no
clinical symptoms in carrier animals, as was previously described for cmr. To our knowledge, this is the
first reported case of canine multifocal retinopathy in the AS breed. Further investigations are under way.
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Abstract
A 1-year-old Australian Shepherd (AS) was presented for a routine hereditary eye examination.
During the examination multiple raised, brown to orange lesions were noted in the fundus, which
could not be attributed to a known retinal disease in this breed. As they clinically most closely
resembled canine multifocal retinopathy (cmr) and no indication of an acquired condition was
found, genetic tests for BEST1 gene mutations were performed. These showed the dog to be
homozygous for the cmr1 (C73T/R25X) gene defect. Furthermore, ultrasound (US),
electroretinography (ERG), and optical coherence tomography were performed, confirming
changes typical for cmr. Subsequently, the AS pedigree members were genetically and clinically
tested, demonstrating autosomal recessive inheritance with no clinical symptoms in carrier
animals, as was previously described for cmr. To our knowledge, this is the first reported case of
canine multifocal retinopathy in the AS breed. Further investigations are under way.

Keywords
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INTRODUCTION
Bestrophinopathies are a group of retinal diseases in which BEST1, a gene necessary for
retinal pigment epithelium (RPE) function, is mutated.1 In humans, this can lead to an earlyonset vitelliform macular dystrophy called Best disease, 2 adult-onset foveomacular
vitelliform dystrophy (AOFVD),3 autosomal dominant vitreoretinochoroidopathy
(ADVIRC),4 and autosomal recessive bestrophinopathy (ARB).5
It has been shown that a clinically and genetically comparable disease exists in dogs, termed
canine multifocal retinopathy (cmr).6,7 To date, three genetically different mutations were
identified in dogs exhibiting the cmr phenotype. The most widespread of these, cmr1 (C73T/
R25X), was found to segregate thus far in seven individual Mastiff-derived breeds: Great
Pyrenees, English Mastiff, Bullmastiff, 6 Dogue de Bordeaux, Italian Mastiff,7 Bulldog, and
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Perro de Presa Canario (Guziewicz KE and Zangerl B, unpublished). Contrary, the cmr2, a
missense mutation (G482A/Gly161Asp), and cmr3, a frameshift mutation (C1388del/
Pro463FS), are ‘private’ and, respectively, segregate in Coton de Tulear and Lapponian
Herders only.6,7
Despite the molecular differences, the disease manifests clinically as multifocal retinal
bullae early in life, which progress until six to twelve months of age.8 It seems to be selflimited in most cases, although vision loss has also been described.7 So far, a specific
treatment is not known, neither for cmr nor for human bestrophinopathies.9,10
This case report details the clinical, ultrasonographic, electroretinographic, optical
coherence tomographical (OCT), and genetic findings in an Australian Shepherd (AS).
Clinical and molecular findings led to the diagnosis of cmr1 in this breed.

CASE REPORT
Multiple fundic lesions were detected during a routine ophthalmic examination of a 1-yearold intact female AS following the guidelines of the European College of Veterinary
Ophthalmology hereditary eye disease scheme. The owner had not noted any visual deficits.
The dog was living as a companion dog in a rural area and had only been to Germany and
Austria. It was fed commercial dog food and was routinely vaccinated against canine
distemper, hepatitis, parainfluenza, parvovirosis, leptospirosis, and rabies. It received
deworming medications on a regular basis, the last time 3 months prior to the examination.
On physical examination, the animal was healthy and alert, and abnormalities were limited
to the eyes.
Upon ophthalmic examination, the adnexa, anterior segment, lens, and vitreous were
normal. Funduscopic examination showed multiple, brown to orange lesions, which were
mainly limited to the tapetal fundus (Fig. 1). They mostly were 1 disc diameter in size, but
could extend up to 4× the size of the optic disc and seemed vessel-associated. The bullae
extended into the vitreous and had a bright border.
Despite the size and the number of the lesions, maze testing in the dark and ambient light as
well as vision tests were considered normal and the dog was able to navigate in new areas
with ease. Complete blood count and serum chemistry profile were within normal limits.
Testing for toxoplasmosis showed no antibody titer. No progression of the lesions was noted
2 weeks after the initial examination. The presumptive diagnosis of cmr was made, but
differential diagnoses included acquired inflammatory lesions, generalized neoplasia with
metastases into the eyes, nutritional retinopathies, and congenital or genetic changes in the
retina.
No signs of uveitis or choroiditis were present at either examination ruling out causes of
exudative retinal detachments. Tapetal hyper-reflectivity as a sign of a reattached or
degenerated retina as well as black pigmented centers with a hyper-reflective rim like in
post-inflammatory lesions were also not observed. Furthermore, the clinical laboratory
results showed no abnormalities. A systemic neoplastic affection seemed unlikely due to
nonprogression of the lesion, the good body condition, and age of the dog. The multifocal
presence of the retinal detachments could have led to the diagnosis of multifocal retinal
dysplasia, but this disease normally has an opaque and vermiform or donut-like appearance.
As the disease resembled clinically cmr, EDTA blood was collected according to standard
veterinary care and tested for known canine BEST1 mutations (OptiGen, LLC). Genetic
results identified the dog to be homozygous for the cmr1 gene defect.

Vet Ophthalmol. Author manuscript; available in PMC 2013 September 30.

Hoffmann et al.

Page 3

Subsequently, the owner consented to further examinations to better characterize the fundus
changes. Therefore, ultrasonography (US), electroretinography (ERG), and OCT were
performed under sedation because of the dog’s anxiety. For the latter, an intravenous dose of
0.04 mg/kg of Medetomidin was used. The cornea was topically anesthetized with 0.5%
proparacaine (Proparakain-POS; Ursapharm, Saarbruecken, Germany). Ultrasound
(Cineloop Scan-S; Quantel Medical, Clermont-Ferrand, France) was performed with an
ophthalmic 10 MHz transducer scanning the intraocular and orbital contents. It showed
multiple semi-curved hyperechoic lines that protruded into the vitreous and were consistent
with focal, serous retinal detachments (Fig. 2).
Scotopic and photopic electroretinograms (RETIport; S&V Technologies AG, Hennigsdorf,
Germany) of the dog as well as a breed-, age-, and gender-matched control were recorded.
Mydriasis was accomplished with topical application of tropicamide 5% (Mydrum,
Ankerpharm, Germany), and the dogs were dark-adapted for 10 min. Two subdermal needle
electrodes (GVB-geliMED E.Kfm, Bad Segeberg, Germany) were placed as previously
described.11 A Kojiman corneal contact lens was used as an active electrode and as an eyelid
speculum. Its in-build 4WLED was used as photostimulator (3.0 cds/m2 standard flash, 300
Hz) and it was stabilized on the cornea with a dexpanthenol gel (Corneregel, Bausch &
Lomb, Berlin, Germany). Each ERG response was averaged 20 times, and the cut-off filter
was set at 300 Hz. Scotopic and photopic electroretinography revealed a significant
difference in the b-waves in the affected dog and the control (Fig. 3). Optical coherence
tomography (OCT) was completed only in the affected dog (SPECTRALIS® Tracking Laser
Tomographie with Eye Tracking; Heidelberg Engineering, Heidelberg, Germany). The
vitreous and retina as well as the bullous retinal lesions were photographed. The lesions
were measured, again confirming the serous retinal detachments. Focal serous
accumulations, which were optically opaque in some cases, were observed subretinally. In
places, where both occurred, a gravity stratification was visible, that is, the serous material
was located above the opaque one. In this area, the retina was thickened compared to the
thickness of the retina that was attached on either side of the bulla (Fig. 4). The thickness of
the affected and unchanged areas was 88–216 and 59–67 μm, respectively, measured from
internal limiting membrane to external limiting membrane.
As clinical and genetic results were highly consistent with a diagnosis of cmr1, five directly
related animals were clinically examined and tested for the cmr1 mutation. While none of
the relatives showed clinical abnormalities, the parents of the affected dog were identified to
be cmr1 carriers, and other relatives were genetically normal (Fig. 5). Additionally, the
investigation into genetic markers surrounding the original mutation suggested that it is
identical-by-descent (IBD) with the locus originally described in Mastiffrelated breeds (data
not shown).

DISCUSSION
To date, clinical implications of cmr are not clearly understood. Ocular symptoms range
from normal to severe visual impairment. The affected AS was presented for a routine eye
examination without the indication of reduced vision despite the presence of large and
prominent retinal lesions. As there were no signs of an infectious origin for the retinal
changes or other known potential causes, striking resemblance to already described cases of
cmr suggested this disorder as potential diagnosis.8,11 Ophthalmic ultrasound showed
multiple zones of dehiscence of the sensory retina from the RPE which can be indicative,
but not specific for cmr.11
Electrodiagnostic testing was distinctively different in the affected animal from a breed-,
age-, and gender-matched control. Although not common with cmr, sporadic cases with
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altered ERG responses have previously been observed.11 The reason for this is unknown. It
may be possible that the severity or location of the lesions contributed to the diminishing of
the b-wave, although the dog seemed not to be visually impaired by this. It may be
worthwhile to conduct ERG’s in affected ASs with less prominent changes to see whether
the severity of the lesions correlates with b-wave amplitude. The OCT examination further
strengthened the diagnosis of cmr as it confirmed the serous retinal detachments and the
subretinal infiltrate. This infiltrate has been identified in other cases of this disease11 as well
as in humans affected with Best’s disease.12 The thickness of the affected areas was unusual
for cmr11 and is not typically seen in Best’s disease either.13 In contrast to a previous
report,11 the retina did not seem thinned compared to the thickness of the retina that was
attached on either side of the bulla (Fig. 4). This may be due to the young age of the animal
and the unknown onset of individual lesions. Thus, thinning of the retina may potentially
occur at a later stage.
Genotype analyses of the affected dog and its immediate family not only confirmed the
diagnosis of cmr1, but also revealed an identity-by-descent at the BEST1 locus between AS
and Mastiff breeds. This suggests that ASs either share some common ancestry with
Mastiff-related breeds or at least some lines may have been subjected to a recent admixture.
As the latter is not supported by the documented breeding history, these findings not only
have an immediate impact on the AS breed, but also suggest that cmr1 may indeed reflect an
old mutation with the potential to affect more breeds than initially thought.
In conclusion, a genetic test for cmr1 is warranted for ASs suspicious for the disease.
Furthermore, cmr should be added to the list of differential diagnoses in retinal changes in
this breed.
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Figure 1.

Right fundus photograph of the affected Australian Shepherd with multiple, brown to orange
lesions.
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Figure 2.

Ultrasonogram of the right eye with a serous detachment. Note the hyperechoic line that
protrudes into the vitreous (arrow).
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Figure 3.

Electrophysiology measurements of the studied Australian Shepherd case (a) and the control
dog (b). Scotopic measurement on top, and photopic measurement below. Note the
diminished b-wave in (a).
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Figure 4.

Optical coherence tomography in affected Australian Shepherd. The green line in the left
photograph shows the scanned area depicted on the right side of the figure. Note the focal
detachments, the serous accumulations with gravity stratification, and the thickened retina
over the larger bulla.
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Figure 5.

(a) Australian Shepherd pedigree segregating cmr1 mutation (C, normal allele; T, mutant
allele). The affected case is denoted by the red arrow. (b) Sequencing chromatograms
illustrating the C73T/R25X mutation in the canine BEST1 gene (top panel: homozygous
affected; middle panel: heterozygous carrier; bottom panel: homozygous for the normal
allele).
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